AZIMAX

This brand name is authorized in Hong Kong, Singapore, South Africa

Active ingredients

The drug AZIMAX contains one active pharmaceutical ingredient (API):

1 Azithromycin UNII F94OW58Y8V - AZITHROMYCIN, UNSPECIFIED FORM

Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation. Read about Azithromycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AZIMAX Tablet	Web Search	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 62519
Country: SG	Health Sciences Authority	Identifier(s): 15065P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/20.1.1/0165, 45/20.1.1/0246